We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CF:NYSECF Industries Holdings, Inc. Analysis

Data as of 2026-06-14 - not real-time

$109.48

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

CF Industries is trading at $109.48, just above the identified support of $106.17 and below its 20‑day (116.35) and 50‑day (120.48) SMAs, suggesting short‑term pressure despite a neutral 200‑day SMA (98.56). The RSI of 40 and a bearish MACD histogram reinforce a cautious near‑term outlook, while the 30‑day volatility of 47% and a negative beta (-0.80) highlight heightened price swings and an inverse market correlation. Fundamentally, the company posted a 19.4% revenue increase, strong operating (33.6%) and profit margins (23.7%), and a robust ROE of 27%. Valuation metrics are compelling: a trailing P/E of 9.9, a price‑to‑book of 3.15, and a DCF‑derived fair value of $195 imply the stock is undervalued with significant upside. The dividend yield of 1.8% is supported by a low 18% payout ratio and ample cash flow. Recent Q1 2026 results beat expectations, driven by tighter global nitrogen markets and higher fertilizer prices linked to geopolitical tensions, reinforcing the earnings momentum.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering just above key support with bearish MACD
  • Elevated short‑term volatility and negative beta
  • Recent earnings beat but technical indicators signal caution

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant valuation gap to DCF fair value
  • Strong earnings growth and high ROE
  • Sustainable dividend with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Long‑term fertilizer demand and favorable nitrogen market fundamentals
  • Robust cash generation and manageable debt levels
  • Consistent dividend policy and attractive upside potential

Key Metrics & Analysis

Financial Health

Revenue Growth19.40%
Profit Margin23.73%
P/E Ratio9.9
ROE27.30%
ROA11.34%
Debt/Equity43.85
P/B Ratio3.1
Op. Cash Flow$2.7B
Free Cash Flow$1.1B

Technical Analysis

TrendNeutral
RSI40.1
Support$106.17
Resistance$128.78
MA 20$116.35
MA 50$120.48
MA 200$98.56
MACDBearish
VolumeStable
Fear & Greed Index89.86

Valuation

Fair Value$195.21
Target Price$127.63
Upside/Downside16.58%
GradeUndervalued
TypeGrowth
Dividend Yield1.83%

Risk Assessment

Beta-0.80
Volatility47.38%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.